Groupe Bruxelles Lambert SA (EBR:GBLB)
73.60
-1.20 (-1.60%)
Jul 31, 2025, 5:35 PM CET
Intra-Cellular Therapies Market Cap
Groupe Bruxelles Lambert has a market cap or net worth of €9.04 billion as of July 31, 2025. Its market cap has increased by 2.25% in one year.
Market Cap
9.04B
Enterprise Value
15.48B
Revenue
6.57B
Ranking
n/a
PE Ratio
278.89
Stock Price
$73.60
Market Cap Chart
Since April 10, 1996, Groupe Bruxelles Lambert's market cap has increased from 3.01B to 9.04B, an increase of 200.41%. That is a compound annual growth rate of 3.82%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 30, 2025 | 9.18B | 9.48% |
Dec 31, 2024 | 8.39B | -11.38% |
Dec 29, 2023 | 9.47B | -10.97% |
Dec 30, 2022 | 10.63B | -27.62% |
Dec 31, 2021 | 14.69B | 16.21% |
Dec 31, 2020 | 12.64B | -13.81% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
KBC Group NV | 36.25B |
ageas | 11.35B |
Sofina Société Anonyme | 8.99B |
KBC Ancora | 4.91B |
Brederode | 3.26B |
Gimv NV | 1.56B |
TINC NV | 489.70M |
Compagnie du Bois Sauvage | 416.08M |